GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Current Ratio

Lifeline Scientific (LSE:LSI) Current Ratio : 4.41 (As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Lifeline Scientific's current ratio for the quarter that ended in Jun. 2016 was 4.41.

Lifeline Scientific has a current ratio of 4.41. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Lifeline Scientific's Current Ratio or its related term are showing as below:

LSE:LSI' s Current Ratio Range Over the Past 10 Years
Min: 2.8   Med: 3.52   Max: 6.26
Current: 4.41

During the past 12 years, Lifeline Scientific's highest Current Ratio was 6.26. The lowest was 2.80. And the median was 3.52.

LSE:LSI's Current Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.7 vs LSE:LSI: 4.41

Lifeline Scientific Current Ratio Historical Data

The historical data trend for Lifeline Scientific's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Current Ratio Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.58 3.52 3.30 2.80 3.89

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.84 2.80 3.05 3.89 4.41

Competitive Comparison of Lifeline Scientific's Current Ratio

For the Medical Devices subindustry, Lifeline Scientific's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifeline Scientific's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's Current Ratio distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's Current Ratio falls into.



Lifeline Scientific Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Lifeline Scientific's Current Ratio for the fiscal year that ended in Dec. 2015 is calculated as

Current Ratio (A: Dec. 2015 )=Total Current Assets (A: Dec. 2015 )/Total Current Liabilities (A: Dec. 2015 )
=15.575/4.007
=3.89

Lifeline Scientific's Current Ratio for the quarter that ended in Jun. 2016 is calculated as

Current Ratio (Q: Jun. 2016 )=Total Current Assets (Q: Jun. 2016 )/Total Current Liabilities (Q: Jun. 2016 )
=16.873/3.826
=4.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeline Scientific  (LSE:LSI) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Lifeline Scientific Current Ratio Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.

Lifeline Scientific (LSE:LSI) Headlines

From GuruFocus

Life Storage, Inc. Announces Dividend on Common Stock

By Business Wire Business Wire 04-01-2022

Life Storage, Inc. Raises Quarterly Common Stock Dividend by 11%

By Business Wire Business Wire 01-03-2023

Life Storage Inc (LSI) CEO Joseph Saffire Sold $585,560 of Shares

By GuruFocus Research GuruFocus Editor 12-21-2021

Life Storage, Inc. Releases 2022 Sustainability Report

By Business Wire Business Wire 06-23-2022

Life Storage, Inc. Reviewing Unsolicited Proposal from Public Storage

By Business Wire Business Wire 02-06-2023

Life Storage, Inc. Announces Executive Leadership Succession

By Business Wire Business Wire 10-25-2022